ABSTRACT

Interferon-B 1a and SARS Coronavirus Replication   [open pdf - 2MB]

A global outbreak of severe acute respiratory syndrome (SARS) caused by a novel coronavirus began in March 2003. The rapid emergence of SARS and the substantial illness and death it caused have made it a critical public health issue. Because no effective treatments are available, an intensive effort is under way to identify and test promising antiviral drugs. This document reports that recombinant human Interferon-B 1a potently inhibits SARS coronavirus replication in vitro.

Author:
Publisher:
Date:
2004-02
Series:
Copyright:
Public Domain
Retrieved From:
Center for Disease Control and Prevention: www.cdc.gov
Format:
pdf
Media Type:
application/pdf
Source:
Emerging Infectious Diseases (February 2004), v.10, no.2, p. 317-319
URL:
Help with citations